Tianjin Ringpu Bio-TechnologyLtd Dividends and Buybacks
Dividend criteria checks 6/6
Tianjin Ringpu Bio-TechnologyLtd is a dividend paying company with a current yield of 2.09% that is well covered by earnings.
Key information
2.1%
Dividend yield
0.7%
Buyback Yield
| Total Shareholder Yield | 2.8% |
| Future Dividend Yield | 3.0% |
| Dividend Growth | 10.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.400 |
| Payout ratio | 43% |
Recent dividend and buyback updates
Recent updates
There's No Escaping Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Muted Earnings Despite A 29% Share Price Rise
Nov 26
Is There An Opportunity With Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) 42% Undervaluation?
Nov 25Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Nov 05These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More
Oct 08Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 26Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet
Aug 23Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Apr 05Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity
Mar 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300119's dividends per share have been stable in the past 10 years.
Growing Dividend: 300119's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Tianjin Ringpu Bio-TechnologyLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300119) | 2.1% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (300119) (up to 3 years) | 3.0% |
Notable Dividend: 300119's dividend (2.09%) is higher than the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 300119's dividend (2.09%) is in the top 25% of dividend payers in the CN market (2.07%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (43.5%), 300119's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (56.5%), 300119's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 10:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Ringpu Bio-Technology Co.,Ltd. is covered by 19 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jia Chen | Changjiang Securities Co. LTD. |
| Xu Qing Liu | Chasing Securities |
| Junhao Fan | China International Capital Corporation Limited |